Esposito Pamela
Insider CIK 1744425 · REPL Chief Business Officer · KYMR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-06-24 | 2026-06-25 | 6,068 | — | $0 | 6,068 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-05-19 | 2026-05-19 | 1,000 | — | $0 | 9,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-05-19 | 2026-05-19 | 1,000 | $31.20 | $31.2K | 1,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-03-20 | 2026-03-20 | 2,500 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-03-20 | 2026-03-20 | 2,500 | $49.10 | $122.8K | 2,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-20 | 2026-03-20 | 700 | $77.71 | $54.4K | 1,800 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-20 | 2026-03-20 | 600 | $79.24 | $47.5K | 1,200 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-20 | 2026-03-20 | 1,200 | $79.94 | $95.9K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-02-20 | 2026-02-20 | 2,500 | — | $0 | 2,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-02-20 | 2026-02-20 | 600 | $88.10 | $52.9K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-02-20 | 2026-02-20 | 1,900 | $87.06 | $165.4K | 600 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-02-20 | 2026-02-20 | 2,500 | $49.10 | $122.8K | 2,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-01-20 | 2026-01-20 | 3,000 | — | $0 | 10,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-01-20 | 2026-01-20 | 2,500 | — | $0 | 5,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-01-20 | 2026-01-20 | 4,900 | $67.99 | $333.2K | 200 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-01-20 | 2026-01-20 | 400 | $66.68 | $26.7K | 5,100 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-01-20 | 2026-01-20 | 2,500 | $49.10 | $122.8K | 5,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-01-20 | 2026-01-20 | 3,000 | $31.20 | $93.6K | 3,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-01-20 | 2026-01-20 | 200 | $68.52 | $13.7K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-12-17 | 2025-12-17 | 12,563 | — | $0 | 7,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-12-17 | 2025-12-17 | 3,000 | — | $0 | 13,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-12-17 | 2025-12-17 | 12,000 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-17 | 2025-12-17 | 14,505 | $81.56 | $1.18M | 13,058 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-12-17 | 2025-12-17 | 12,563 | $49.10 | $616.8K | 12,563 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-12-17 | 2025-12-17 | 12,000 | $27.67 | $332.0K | 24,563 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-17 | 2025-12-17 | 1,000 | $84.07 | $84.1K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-17 | 2025-12-17 | 4,099 | $83.45 | $342.1K | 1,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-17 | 2025-12-17 | 7,959 | $82.34 | $655.3K | 5,099 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-12-17 | 2025-12-17 | 3,000 | $31.20 | $93.6K | 27,563 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-06-25 | 2025-06-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-06-03 | 2025-06-03 | 5,000 | — | $0 | 24,127 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-06-03 | 2025-06-03 | 5,000 | $29.55 | $147.8K | 5,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-06-03 | 2025-06-03 | 5,000 | $49.04 | $245.2K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-12-02 | 2024-12-02 | 2,500 | — | $0 | 29,127 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-12-02 | 2024-12-02 | 2,500 | $49.00 | $122.5K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-12-02 | 2024-12-02 | 2,500 | $29.55 | $73.9K | 2,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-09-17 | 2024-09-17 | 8,500 | — | $0 | 31,627 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-09-17 | 2024-09-17 | 5,000 | — | $0 | 7,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-09-17 | 2024-09-17 | 5,000 | $14.18 | $70.9K | 13,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-09-17 | 2024-09-17 | 7,150 | $48.75 | $348.6K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-09-17 | 2024-09-17 | 6,350 | $47.75 | $303.2K | 7,150 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-09-17 | 2024-09-17 | 8,500 | $29.55 | $251.2K | 8,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 16,000 | — | $0 | 16,000 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2023-09-12 | 2023-09-13 | 300 | — | $0 | 86,033 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2023-09-12 | 2023-09-13 | 300 | $3.30 | $990 | 263,736 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2023-09-12 | 2023-09-13 | 300 | $20.00 | $6.0K | 263,436 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2023-09-11 | 2023-09-13 | 5,358 | — | $0 | 86,333 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2023-09-11 | 2023-09-13 | 5,358 | $20.01 | $107.2K | 263,436 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2023-09-11 | 2023-09-13 | 5,358 | $3.30 | $17.7K | 268,794 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2023-08-22 | 2023-08-24 | 5,000 | — | $0 | 35,750 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2023-08-22 | 2023-08-24 | 13,600 | — | $0 | 91,691 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2023-08-22 | 2023-08-24 | 18,600 | $20.01 | $372.2K | 263,436 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2023-08-22 | 2023-08-24 | 5,000 | $15.50 | $77.5K | 282,036 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2023-08-22 | 2023-08-24 | 13,600 | $3.30 | $44.9K | 277,036 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2023-08-11 | 2023-08-15 | 1,400 | — | $0 | 105,291 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2023-08-11 | 2023-08-15 | 1,400 | $20.00 | $28.0K | 263,436 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2023-08-11 | 2023-08-15 | 1,400 | $3.30 | $4.6K | 264,836 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2023-07-10 | 2023-07-11 | 15,000 | — | $0 | 106,691 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2023-07-10 | 2023-07-11 | 5,000 | — | $0 | 40,750 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2023-07-10 | 2023-07-11 | 2,077 | $21.12 | $43.9K | 263,436 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2023-07-10 | 2023-07-11 | 15,000 | $3.30 | $49.5K | 278,436 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2023-07-10 | 2023-07-11 | 5,000 | $15.50 | $77.5K | 283,436 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2023-07-10 | 2023-07-11 | 17,923 | $21.63 | $387.7K | 265,513 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2023-05-16 | 2023-05-18 | 5,966 | $18.05 | $107.7K | 263,436 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2023-04-01 | 2023-04-04 | 60,000 | — | $0 | 60,000 | SEC↗ |
| REPL Replimune Group, Inc. | A Award | 2023-04-01 | 2023-04-04 | 40,000 | — | $0 | 269,402 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2022-12-09 | 2022-12-13 | 15,000 | — | $0 | 36,203 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2022-12-09 | 2022-12-13 | 15,000 | $25.03 | $375.4K | 229,402 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2022-12-09 | 2022-12-13 | 15,000 | $1.01 | $15.2K | 244,402 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 12,000 | — | $0 | 12,000 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2022-05-16 | 2022-05-18 | 3,507 | $14.59 | $51.2K | 229,402 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2022-04-01 | 2022-04-05 | 34,125 | — | $0 | 34,125 | SEC↗ |
| REPL Replimune Group, Inc. | A Award | 2022-04-01 | 2022-04-05 | 22,750 | — | $0 | 232,909 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-08-05 | 2021-08-06 | 25,800 | — | $0 | 45,750 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-08-05 | 2021-08-06 | 25,800 | $35.09 | $905.3K | 210,159 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-08-05 | 2021-08-06 | 25,800 | $15.50 | $399.9K | 235,959 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-08-04 | 2021-08-06 | 4,200 | — | $0 | 71,550 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-08-04 | 2021-08-06 | 4,200 | $35.00 | $147.0K | 210,159 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-08-04 | 2021-08-06 | 4,200 | $15.50 | $65.1K | 214,359 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-07-21 | 2021-07-22 | 12,538 | — | $0 | 51,203 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-07-21 | 2021-07-22 | 12,538 | $1.01 | $12.7K | 222,697 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-07-21 | 2021-07-22 | 12,538 | $33.17 | $415.9K | 210,159 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-07-20 | 2021-07-22 | 4,862 | — | $0 | 63,741 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-07-20 | 2021-07-22 | 4,862 | $33.05 | $160.7K | 210,159 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-07-20 | 2021-07-22 | 4,862 | $1.01 | $4.9K | 215,021 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-07-15 | 2021-07-19 | 4,600 | — | $0 | 68,603 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-07-15 | 2021-07-19 | 4,600 | $33.37 | $153.5K | 210,159 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-07-15 | 2021-07-19 | 4,600 | $1.01 | $4.6K | 214,759 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,063 | — | $0 | 20,063 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2021-04-01 | 2021-04-05 | 51,250 | — | $0 | 51,250 | SEC↗ |
| REPL Replimune Group, Inc. | A Award | 2021-04-01 | 2021-04-05 | 34,165 | — | $0 | 210,159 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-01-19 | 2021-07-19 | 5,727 | — | $0 | 73,203 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-01-19 | 2021-07-19 | 5,727 | $1.01 | $5.8K | 181,721 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-01-19 | 2021-07-19 | 600 | $43.24 | $25.9K | 181,121 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-01-19 | 2021-07-19 | 5,127 | $42.38 | $217.3K | 175,994 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-01-19 | 2021-01-19 | 5,727 | — | $0 | 73,203 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-01-19 | 2021-01-19 | 600 | $43.24 | $25.9K | 181,121 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-01-19 | 2021-01-19 | 5,127 | $42.38 | $217.3K | 175,994 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-01-19 | 2021-01-19 | 5,727 | $1.01 | $5.8K | 181,721 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-01-15 | 2021-07-19 | 29,273 | — | $0 | 78,930 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-01-15 | 2021-07-19 | 29,273 | $1.01 | $29.6K | 205,267 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-01-15 | 2021-07-19 | 29,273 | $43.58 | $1.28M | 175,994 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-01-15 | 2021-01-19 | 29,273 | — | $0 | 78,930 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-01-15 | 2021-01-19 | 29,273 | $1.01 | $29.6K | 205,267 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-01-15 | 2021-01-19 | 29,273 | $43.58 | $1.28M | 175,994 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-01-14 | 2021-07-19 | 20,000 | — | $0 | 108,203 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-01-14 | 2021-07-19 | 20,000 | $1.01 | $20.2K | 195,994 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-01-14 | 2021-07-19 | 20,000 | $45.02 | $900.4K | 175,994 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2021-01-14 | 2021-01-19 | 20,000 | — | $0 | 108,203 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2021-01-14 | 2021-01-19 | 20,000 | $45.02 | $900.4K | 175,994 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2021-01-14 | 2021-01-19 | 20,000 | $1.01 | $20.2K | 195,994 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2020-12-23 | 2020-12-28 | 50,704 | — | $0 | 32,758 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2020-12-23 | 2020-12-28 | 50,704 | $1.75 | $88.7K | 175,994 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2020-12-11 | 2020-12-15 | 12,590 | — | $0 | 121,691 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2020-12-11 | 2020-12-15 | 12,590 | $3.30 | $41.5K | 125,290 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2020-10-14 | 2020-10-16 | 16,000 | — | $0 | 128,203 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2020-10-14 | 2020-10-16 | 16,000 | $1.01 | $16.2K | 128,700 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2020-10-14 | 2020-10-16 | 9,000 | $35.04 | $315.4K | 112,700 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2020-10-14 | 2020-10-16 | 7,000 | $30.15 | $211.1K | 121,700 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2020-09-04 | 2020-09-09 | 40,127 | — | $0 | 40,127 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2020-08-31 | 2020-09-01 | 5,000 | — | $0 | 144,203 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2020-08-31 | 2020-09-01 | 5,000 | $27.05 | $135.3K | 112,700 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2020-08-31 | 2020-09-01 | 5,000 | $1.01 | $5.0K | 117,700 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2020-04-01 | 2020-04-02 | 85,450 | — | $0 | 85,450 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2019-12-20 | 2019-12-23 | 25,700 | — | $0 | 83,462 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2019-12-20 | 2019-12-23 | 25,700 | $1.75 | $45.0K | 112,700 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2019-04-01 | 2019-04-03 | 75,750 | — | $0 | 75,750 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2018-12-13 | 2018-12-17 | 87,000 | — | $0 | 109,162 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2018-12-13 | 2018-12-17 | 87,000 | $1.75 | $152.3K | 87,000 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2018-07-24 | 2018-07-26 | 70,000 | — | $0 | 70,000 | SEC↗ |